ATAD1 and neoplasm: To confirm whether ATAD1 alteration is associated with clinical outcome, we employ Kaplan–Meier analysis to examine the 5-year progression free survival rate of patients harboring altered (n = 144) or unaltered ATAD1 (n = 10,258) in the tumor tissue.